Skip Nav Destination
Issues
Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity.
Diabetes Care March 1999, Vol.22, 377-381. doi:https://doi.org/10.2337/diacare.22.3.377
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
Diabetes Care March 1999, Vol.22, 382-387. doi:https://doi.org/10.2337/diacare.22.3.382
Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?
Diabetes Care March 1999, Vol.22, 388-393. doi:https://doi.org/10.2337/diacare.22.3.388
Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.
Diabetes Care March 1999, Vol.22, 394-398. doi:https://doi.org/10.2337/diacare.22.3.394
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
J E Shaw; P Z Zimmet; M de Courten; G K Dowse; P Chitson; H Gareeboo; F Hemraj; D Fareed; J Tuomilehto; K G Alberti
Diabetes Care March 1999, Vol.22, 399-402. doi:https://doi.org/10.2337/diacare.22.3.399
Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
Diabetes Care March 1999, Vol.22, 403-408. doi:https://doi.org/10.2337/diacare.22.3.403
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
B Littorin; G Sundkvist; W Hagopian; M Landin-Olsson; A Lernmark; J Ostman; H J Arnqvist; G Blohmé; J Bolinder; J W Eriksson; F Lithner; B Scherstén; L Wibell
Diabetes Care March 1999, Vol.22, 409-412. doi:https://doi.org/10.2337/diacare.22.3.409
Plasma leptin concentrations in Pima Indians living in drastically different environments.
Diabetes Care March 1999, Vol.22, 413-417. doi:https://doi.org/10.2337/diacare.22.3.413
Effect of selective screening for gestational diabetes.
Diabetes Care March 1999, Vol.22, 418-421. doi:https://doi.org/10.2337/diacare.22.3.418
Diabetic nephropathy is associated with an increased familial risk of stroke.
Diabetes Care March 1999, Vol.22, 422-425. doi:https://doi.org/10.2337/diacare.22.3.422
Prevalence of undiagnosed diabetes and abnormalities of carbohydrate metabolism in a U.S. Army population.
Diabetes Care March 1999, Vol.22, 426-429. doi:https://doi.org/10.2337/diacare.22.3.426
Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain.
J C Mbanya; J K Cruickshank; T Forrester; B Balkau; J Y Ngogang; L Riste; A Forhan; N M Anderson; F Bennett; R Wilks
Diabetes Care March 1999, Vol.22, 434-440. doi:https://doi.org/10.2337/diacare.22.3.434
Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project.
Diabetes Care March 1999, Vol.22, 441-447. doi:https://doi.org/10.2337/diacare.22.3.441
Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study.
Diabetes Care March 1999, Vol.22, 453-458. doi:https://doi.org/10.2337/diacare.22.3.453
Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
Diabetes Care March 1999, Vol.22, 459-462. doi:https://doi.org/10.2337/diacare.22.3.459
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
C Lalli; M Ciofetta; P Del Sindaco; E Torlone; S Pampanelli; P Compagnucci; M G Cartechini; L Bartocci; P Brunetti; G B Bolli
Diabetes Care March 1999, Vol.22, 468-477. doi:https://doi.org/10.2337/diacare.22.3.468
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
Diabetes Care March 1999, Vol.22, 478-483. doi:https://doi.org/10.2337/diacare.22.3.478
Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
Diabetes Care March 1999, Vol.22, 484-490. doi:https://doi.org/10.2337/diacare.22.3.484
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
Diabetes Care March 1999, Vol.22, 491-494. doi:https://doi.org/10.2337/diacare.22.3.491
Natural history of diabetic gastroparesis.
Diabetes Care March 1999, Vol.22, 503-507. doi:https://doi.org/10.2337/diacare.22.3.503
American Diabetes Association Annual Meeting, 1998. Insulin resistance, exercise, and obesity.
Diabetes Care March 1999, Vol.22, 517-522. doi:https://doi.org/10.2337/diacare.22.3.517
Pseudohypoparathyroidism, obesity, and type 2 diabetes. A hypothesis.
Diabetes Care March 1999, Vol.22, 523. doi:https://doi.org/10.2337/diacare.22.3.523
Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.
Diabetes Care March 1999, Vol.22, 524. doi:https://doi.org/10.2337/diacare.22.3.524b
C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes.
Diabetes Care March 1999, Vol.22, 525-526. doi:https://doi.org/10.2337/diacare.22.3.525
Antioxidant effects of gliclazide and soluble adhesion molecules in type 2 diabetes.
Diabetes Care March 1999, Vol.22, 528-530. doi:https://doi.org/10.2337/diacare.22.3.528a
Keep metformin guidelines intact.
Diabetes Care March 1999, Vol.22, 532-533. doi:https://doi.org/10.2337/diacare.22.3.532
Poor level of care among diabetic patients. Is that a unique picture?
Diabetes Care March 1999, Vol.22, 533-535. doi:https://doi.org/10.2337/diacare.22.3.533
Screening low-risk women for gestational diabetes mellitus. Let's not muddy the waters further.
Diabetes Care March 1999, Vol.22, 535. doi:https://doi.org/10.2337/diacare.22.3.535